| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.39 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |